Microarray technology in the study of genetic determinants of cardiovascular diseases

• Authors: Anna Gluba , Jacek Rysz , Tadeusz Pietrucha
• Languages of publication: EN

Abstracts

EN

Microarray, a miniaturized glass slide or membrane with immobilized DNA probes, is a powerful tool for the analysis of mutations, gene expression and sequencing. This technique requires chip (glass slide or membrane) fabrication, preparation of probes and labelled targets, hybridization and data analysis. Microarrays give the possibility to evaluate a wide spectrum of candidate genes, to simultaneously observe interaction of genes, to detect polymorphisms within genes and identify therapeutic targets. Coronary artery disease being a major cause of death, is a disorder influenced by either genetic or environmental factors. Microarray analysis of gene expression can be used to identify genes involved in disease progression and in disease reduction. Chips also allow for the throughput and simultaneous analysis of a great variety of cell types such as cardiomyocytes, monocytes, macrophages, smooth muscle, endothelial, and fibroblasts and chemical mediators involved in cardiovascular disease pathology, their interactions and cumulative effects.

Keywords

EN

Cardiovascular disease; Chip; Microarray; Single nucleotide polymorphism (SNP)

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2009
• Volume: 4
• Issue: 1
• Pages: 1-10

Dates

published

1 - 3 - 2009

online

11 - 2 - 2009

Contributors

author

Anna Gluba

• Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland

author

Jacek Rysz

• Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland

author

Tadeusz Pietrucha

• Departament of Biotechnological Medicine, Medical University of Lodz, Mazowiecka 6/8 street, 92-215, Lodz, Poland

References

• [1] Jain K.K., Biochips for Gene Spotting, Science, 2001, 294, 621–625 http://dx.doi.org/10.1126/science.294.5542.621[Crossref]
• [2] Brazma A, Parkinson H, Schlitt T, Shojatalab M., A quick introduction to elements of biology - cells, molecules, genes, functional genomics, microarrays, 2009, http://www.ebi.ac.uk/microarray/biology_intro_files/ISMB2000.pdf
• [3] Schena M, Shalon D, Davis R.W, O.Brown P., Quantitative monitoring of gene expression patterns, Science, 1995, 270, 467–470 http://dx.doi.org/10.1126/science.270.5235.467[Crossref]
• [4] Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, et al., A Concise Guide to cDNA Microarray Analysis, Biotechniques 2000, 29, 548–562 [PubMed]
• [5] Gwynne P, Heebner G., DNA Chips and Microarrays Part 1, 2001, http://www.sciencemag.org/products/benchtop
• [6] Fodor P.A, Read J.L, Pirrung M.C, Stryer L, Lu A.T, Solas D., Light-directed, spatially addressable parallel chemical synthesis, Science, 1991, 251, 767–773 http://dx.doi.org/10.1126/science.1990438[Crossref]
• [7] Dolan P.L, Wu Y, Ista L K, Metzenberg R.L, Nelson M.A, Lopez G.P., Robust and efficient synthetic method for forming DNA microarrays, Nucleic Acids Research, 2001, 29, e107 http://dx.doi.org/10.1093/nar/29.21.e107[Crossref]
• [8] Ye R W, Wang T, Bedzyk L, Croker K.M, Applications of DNA microarrays in microbial systems. Review article, Journal of Microbiological Methods, 2001, 47, 257–272 http://dx.doi.org/10.1016/S0167-7012(01)00308-6[Crossref]
• [9] Duggan D.J, Bittner M, Chen Y, Meltzer P, Trent J.M, Expression profiling using cDNA microarrays, Nature Genetics supplement, 1999, 21, 10–14 http://dx.doi.org/10.1038/4434[Crossref]
• [10] Telechem International Inc., 2001, www.arrayit.com/Products/Substrates/
• [11] Afanassiev V, Hanemann V, Wölfl S., Preparation of DNA and protein micro arrays on glass slides coated with an agarose film, Nucleic Acids Research, 2000, 28, e66 http://dx.doi.org/10.1093/nar/28.12.e66[Crossref]
• [12] Manning M, Galvin P, Redmond G., A robust procedure for DNA microarray fabrication and screening in the molecular biology laboratory. Application Note, American Biotechnology Laboratory, 2002, 20, 16–18
• [13] Eisen M.B, Brown P.O., DNA Arrays for Analysis of Gene Expression, Methods Enzymol 1999, 303, 179–205. http://dx.doi.org/10.1016/S0076-6879(99)03014-1[Crossref]
• [14] Robinson W.H, Digennaro C, Hueber W, Haab B.B, Kamachi M, Dean E.J, et al., Autoantigen microarrays for multiplex characterization of autoantibody responses, Nature Medicine 2002, 8, 295–301 http://dx.doi.org/10.1038/nm0302-295[Crossref]
• [15] Buhler J, Campbell A.M., Anatomy of a Comparative Gene Expression Study, 2002, http://www.cs.wustl.edu/~jbuhler/research/array
• [16] Affymetrix, 2003, http://www.affymetrix.com/technology/design/index.affx
• [17] Hoffmann F, La Roche, DNA chips: choosy fish hooks, 2004, http://www.roche.com/pages/facets/f22_dna_e.pdf
• [18] Bertone P, Synder M, Advances in functional protein microarray technology, Review, FEBS J 2005, 272,5400–5411 http://dx.doi.org/10.1111/j.1742-4658.2005.04970.x[Crossref]
• [19] Haab B.B, Dunhan M.J, O.Brown P, Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions, Genome Biology, 2001, 2 [Crossref][PubMed]
• [20] Arenkov P, Kukhtin A, Gemmell A, Voloshchuk S, Chupeeva V, Mirzabekov A., Protein Microchips: Use for Immunoassay and Enzymatic Reactions, Analytical Biochemistry 2000, 278, 123–131 http://dx.doi.org/10.1006/abio.1999.4363[Crossref]
• [21] Henke C., DNA-chip technologies. Part 2: State-of-the-art and competing technologies., IVD Technology Magazine, 1998, http://www.devicelink.com/ivdt/archive/98/11/010.html
• [22] Kurella M, Hsiao L.L, Yoshida T, Randall J.D, Chow G, Sarang S.S, Jensen R.V, Gullans S.R. DNA Microarray Analysis of Complex Biologic Processes, Journal of the American Society of Nephrology, 2001, 12, 1072–1078
• [23] Murphy D., Gene Expression Studies Using Microarrays: Principles, Problems, And Prospects, Adv Physiol Educ, 2002,26, 256–270 [PubMed][Crossref]
• [24] Silander K, Axelsson T, Wid′en E, Dahlgren A, Palotie A, Syvänen A.C, Analysis of Genetic Variation in the GenomEUtwin Project, Twin Research, 2003, 6, 391–398. http://dx.doi.org/10.1375/136905203770326394[Crossref]
• [25] Syvänen A.C., Toward genome-wide SNP genotyping, Nature Genetics, 2005, 37, S5–S10. http://dx.doi.org/10.1038/ng1558[Crossref]
• [26] Pastinen T, Raitio M, Lindroos K, Tainola P, Peltonen L, Syvänen A.C, A System for Specific, High-throughput Genotyping by Allele-specific Primer Extension on Microarrays, Genome Research, 2000, 10, 1031–1042 http://dx.doi.org/10.1101/gr.10.7.1031[Crossref]
• [27] O’Meara D, Ahmadian A, Odeberg J, Lundeberg J., SNP typing by apyrase-mediated allele-specific primer extension on DNA microarrays, Nucleic Acids Research, 2002, 30, e75 http://dx.doi.org/10.1093/nar/gnf074[Crossref]
• [28] Jain K.K., Lab-on-Chip and Microarrays, Pharmacogenomics, Lab-on-Chip and Microarrays CHI’s 3rd Annual Conference, 2001, 2, 73–77 [Crossref]
• [29] Chen Z.J, Tew K.D., Amplified Differential Gene Expression Microarray, In: Humana Press, 2004, 95–106
• [30] Matsuzaki H, Loi H, Dong S, Tsai Y.Y, Fang J, Law J, et al., Parallel Genotyping of Over 10,000 SNPs Using a One-Primer Assay on a High-Density Oligonucleotide Array, Genome Research, 2004, 14, 414–425 http://dx.doi.org/10.1101/gr.2014904[Crossref]
• [31] Napoli C, Lerman L.O, Sica V, Lerman A, Tajana G, de Nigris F., Microarray analysis: a novel research tool for cardiovascular scientists and physicians, Heart, 2003, 89, 597–604 http://dx.doi.org/10.1136/heart.89.6.597[Crossref]
• [32] Pastinen T, Perola M, Niini P, Terwilliger J, Salomaa V, Vartiainen E, et al., Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population, Human Molecular Genetics, 1998, 7, 1453–1462 http://dx.doi.org/10.1093/hmg/7.9.1453[Crossref]
• [33] Dzau V.J, Japanese Circulation Society, Cardiovascular Disease in the Post-Genomic Era, 2001, http://www.j-circ.or.jp/english/sessions/reports/65th-ss/dzau.htm
• [34] Kwok P Y, Gu Z., Single nucleotide polymorphism libraries: why and how are we building them?, Mol Med Today, 1999, 5, 538–543 http://dx.doi.org/10.1016/S1357-4310(99)01601-9[Crossref]
• [35] Barrans J.D, Stamatiou D, Liew C., Construction of Human cardiovascular cDNA microarray: portrait of the failing heart, Biochem Biophys Res Comm, 2001, 280, 964–969 http://dx.doi.org/10.1006/bbrc.2000.4137[Crossref]
• [36] Barrans J.D, Allen P.D, Stamatiou D, Dzau V.J, Liew C-C, Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray, Am J Pathol, 2002, 160, 2035–2043
• [37] Chaudhary A.G, Alqahtani M.H, Abuzenadah A, Gari M, Al-Sofyani A.A, Al-Aama J.Y., et al., Mutation analysis in Saudi Duchenne and Becker muscular dystrophy patients using multiplex PCR, Arch Med Sci, 2008, 4, 16–21
• [38] Qi L, Genetic effects, gene-lifestyle interactions, and type 2 diabetes, Cent Eur J Med 2008, 3, 1–7 http://dx.doi.org/10.2478/s11536-007-0051-1[WoS][Crossref]
• [39] Boncler M, Gresner P, Nocun M, Rywaniak J, Dolnik M, Rysz J., et al., Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation, Biochim Biophys Acta, 2007, 1770, 1651–1659 [WoS]
• [40] Stavljenić-Rukavina A, Genetics of cardiovascular disease, eJIFCC, 2003,14
• [41] Topol E.J, McCarthy J, Gabriel S, Moliterno D.J, Rogers W.J, Newby L.K, et al., for the GeneQuest Investigators and Collaborators, Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction, Circulation, 2001,104,2641–2644 http://dx.doi.org/10.1161/hc4701.100910[Crossref]
• [42] Cheek D.J, Cesan A., Genetic Predictors of Cardiovascular Disease: The Use of Chip Technology, J. Cardiovasc. Nurs., 2003, 18, 50–56 http://dx.doi.org/10.1111/j.0889-7204.2003.01934.x[Crossref]
• [43] Tobin M.D, Braund P.S, Burton P.R, Thompson J.R, Steeds R, Channer K, et al., Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study, Eur. Heart J., 2004, 25, 459–467 http://dx.doi.org/10.1016/j.ehj.2003.11.014[Crossref]
• [44] Sanghera D.K, Aston C.E, Saha N, Kamboh M.I., DNA Polymorphisms in Two Paraoxonase Genes (PON1 and PON2) Are Associated with the Risk of Coronary Heart Disease, Am J Hum Genet, 1998, 62, 36–44 http://dx.doi.org/10.1086/301669[Crossref]
• [45] Chen Q, Reis S.E, Kammerer C.M, McNamara D.M, Holubkov R, Sharaf B.L, Sopko G, Pauly D.F, Merz C.N, Kamboh M.I, WISE Study Group., Association between the Severity of Angiographic Coronary Artery Disease and Paraoxonase Gene Polymorphisms in the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study, Am J Hum Genet, 2003, 72, 13–22 http://dx.doi.org/10.1086/345312[Crossref]
• [46] Lawlor D.A, Day I.N.M, Gaunt T.R, Hinks L.J, Briggs P.J, Kiessling M, et al., The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women’s Heart and Health cohort study and a meta-analysis, BMC Genetics, 2004, 5:17 http://dx.doi.org/10.1186/1471-2156-5-17[Crossref]
• [47] Hinds D.A, Stuve L.L, Nilsen G.B, Halperin E, Eskin E, Ballinger D.G, et al. Whole-Genome Patterns of Common DNA Variation in Three Human Populations, Science 2005, 307, 1072–1079 http://dx.doi.org/10.1126/science.1105436[Crossref]
• [48] Reszka E, Jegier B, Wasowicz W, Lelonek M, Banach M, Jaszewski R., Detection of infectious agents by polymerase chain reaction in human aortic wall, Cardiovasc. Pathol., 2008, 17, 297–302. http://dx.doi.org/10.1016/j.carpath.2007.11.002[Crossref]
• [49] Meldrum D., Automation for Genomics, Part Two: Sequencers, Microarrays, and Future Trends. Review, Genome Res., 2000, 10, 1288–1303. http://dx.doi.org/10.1101/gr.157400[Crossref]

Identifiers

DOI

10.2478/s11536-009-0012-y